Mesozeaxanthin formulations for treatment of retinal disorders

  • US 6,329,432 B2
  • Filed: 03/02/2001
  • Issued: 12/11/2001
  • Est. Priority Date: 06/28/1993
  • Status: Expired due to Term
First Claim
Patent Images

1. A pharmaceutical composition comprising an effective dose of meso-zeaxanthin and a carrier or diluent.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×